Evidence map›Paper›PMID 18688785›Full record

ArticlePsycho-oncology2008

Psychological functioning in persons considering genetic counseling and testing for Li-Fraumeni syndrome.

Susan K Peterson, Rebecca D Pentz, Salma K Marani, Patricia A Ward, Amie M Blanco, Denise LaRue, Kristen Vogel, Tamara Solomon, Louise C Strong

Open access · greenAbstract read
In one paragraph

Article in Psycho-oncology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Fear of cancer recurrence in patients undergoing germline genome sequencing.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The psychosocial effects of the Li-Fraumeni Education and Early Detection (LEAD) program on individuals with Li-Fraumeni syndrome.Genetics in medicine : official journal of the American College of Medical Genetics · 2017
    Article
  15. Article
  16. Review
  17. On averages and peaks: how do people integrate attitudes about multiple diseases to reach a decision about multiplex genetic testing?Medical decision making : an international journal of the Society for Medical Decision Making · 2013
    Article
  18. Article
  19. Li-fraumeni syndrome.Genes & cancer · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Susan K PetersonThe University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA. speterso@mdanderson.org
Rebecca D Pentz
Salma K Marani
Patricia A Ward
Amie M Blanco
Denise LaRue
Kristen Vogel
Tamara Solomon
Louise C Strong
The University of Texas MD Anderson Cancer Center · USBaylor College of Medicine · USEmory University · USUniversity of California, San Francisco · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
TRANSCRIPTIONAL REGULATION OF WT-1P01CA034936 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI STRONG, LOUISE C · 1985 to 2010
$26.4M
NCI NIH HHS 5 P30 CA016672NCI NIH HHS CA34936NCI NIH HHS P01 CA034936NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

objectiveLi-Fraumeni syndrome (LFS) confers an increased risk of multiple types of cancer in both children and adults. Clinical genetic testing for deleterious germline p53 gene mutations can identify most LFS-affected families. We evaluated factors associated with cancer-specific distress and perceived self-efficacy in coping with a positive genetic test result among persons at risk of having deleterious p53 mutations.

methodsOne hundred thirty-five persons from 15 LFS-affected families were invited to take part in a study that offered p53 genetic counseling and testing and to complete psychosocial measures.

resultsParticipants (n=92) were more likely to be younger and female than nonparticipants (n=43). In multivariate analyses, greater cancer-specific distress was associated with having a lower quality of life, a higher perceived risk of having a p53 mutation, no personal history of cancer and a greater number of first degree relatives (FDRs) affected with cancer. Lower perceived self-efficacy in coping with a positive test result was associated with greater cancer worry, higher decisional conflict about p53 testing and having no personal history of cancer.

conclusionsIndividual perceptions about cancer risk and p53 genetic testing, as well as personal experience with FDRs' cancer diagnoses and deaths, should be addressed during the counseling and testing process for LFS-affected families.

Indexed as

Adaptation, PsychologicalAdolescentAdultAgedAged, 80 and overConflict, PsychologicalDecision MakingFemaleFollow-Up StudiesGenes, p53Genetic CounselingHumansLi-Fraumeni SyndromeMiddle AgedNeoplasmsPoint Mutation

Identifiers

PMID18688785
PMCPMC9535398
OpenAlexW2098495497

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.